These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38812298)
21. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
22. m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma. Bi Y; Meng D; Wan M; Xu N; Xu Y; Yuan K; Liu P; Fang H; Hu H; Lan S Comput Intell Neurosci; 2022; 2022():9315283. PubMed ID: 35978902 [TBL] [Abstract][Full Text] [Related]
23. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
24. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Hu X; Wu L; Liu B; Chen K Front Immunol; 2021; 12():651056. PubMed ID: 34122409 [TBL] [Abstract][Full Text] [Related]
25. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X Front Immunol; 2022; 13():1017120. PubMed ID: 36189307 [TBL] [Abstract][Full Text] [Related]
26. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment. Fu R; Hong X Biomed Res Int; 2022; 2022():3113857. PubMed ID: 35528175 [TBL] [Abstract][Full Text] [Related]
27. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma. Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761 [TBL] [Abstract][Full Text] [Related]
28. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma. Yang H; Zhao L; Zhang Y; Li FF Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887 [TBL] [Abstract][Full Text] [Related]
29. A novel aging-associated lncRNA signature for predicting prognosis in osteosarcoma. He Y; Huang X; Ma Y; Yang G; Cui Y; Lv X; Zhao R; Jin H; Tong Y; Zhang X; Li J; Peng M Sci Rep; 2024 Jan; 14(1):1386. PubMed ID: 38228673 [TBL] [Abstract][Full Text] [Related]
30. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma. Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232 [TBL] [Abstract][Full Text] [Related]
31. Identification of TNFRSF1A as a potential biomarker for osteosarcoma. Zhang Y; Liu K; Wang J Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759 [TBL] [Abstract][Full Text] [Related]
32. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer. Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096 [TBL] [Abstract][Full Text] [Related]
33. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related]
34. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
35. Identification of two immune subtypes in osteosarcoma based on immune gene sets. Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161 [TBL] [Abstract][Full Text] [Related]
36. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma. Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268 [TBL] [Abstract][Full Text] [Related]
37. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer. Xiao R; Yang M; Tan Y; Ding R; Li D Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952 [TBL] [Abstract][Full Text] [Related]
38. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes. Guo J; Li X; Shen S; Wu X Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564 [TBL] [Abstract][Full Text] [Related]
39. Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis. Wang X; Dou J; Liu M; Zhang Y; Li Y; Tong Z Gene; 2024 Nov; 927():148645. PubMed ID: 38844271 [TBL] [Abstract][Full Text] [Related]
40. A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma. Song Z; Cao X; Wang X; Li Y; Zhang W; Wang Y; Chen L Sci Rep; 2024 Feb; 14(1):4621. PubMed ID: 38409243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]